Neutral lipid storage disease
MONDO:0015611Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.
Also known as: lipidosis with triglyceride storage disease, Chanarin-Dorfman syndrome, lipidosis with triglycerid storage disease
2 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsSub-types
Broader categories
-
New combo therapy for advanced cancers enters early human testing
Disease control Recruiting nowThis early-phase trial is testing a new drug called DCSZ11 alongside standard chemotherapy or immunotherapy in 9 people with advanced or metastatic solid tumors, including head and neck cancer. The main goal is to see if the combination is safe and whether it can shrink tumors. B…
Phase 1/2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Scientists launch worldwide registry to unlock rare Fat-Storage disease
Knowledge-focused Recruiting nowThis study is creating an international registry for people with neutral lipid storage disease (NLSD), a rare condition where fat builds up in cells, especially affecting the heart. Researchers will collect medical history, track disease progression, and look for factors that inf…
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC